Lei H Y, Lee S H, Leir S H
Department of Microbiology and Immunology, National Cheng Kung University College of Medicine, Tainan, Taiwan, Republic of China.
Int Arch Allergy Immunol. 1996 Apr;109(4):407-12. doi: 10.1159/000237270.
Intravenous injection of bovine serum albumin (BSA) into the BSA/CFA-primed ICR mice specifically induced anaphylactic death within 1 h. The anaphylactic death could not be induced until day 8 after sensitization, and sensitization subsisted for more than 3 months. The response was dose dependent; mice challenged with BSA doses higher or equivalent to 25 microgram developed anaphylactic death. The intravenous route was more effective than the intraperitoneal one, while subcutaneous injection was ineffective. Antigen in any of complete Freund's adjuvant, incomplete Freund's adjuvant or aluminum hydroxide could sensitize the mice to develop anaphylactic death. The combination of antigen and the mouse strain or the gender of the mouse determined the susceptibility of the anaphylactic death. AKR, B10.BR, as well as ICR, strains were susceptible. Antigen of HoGG induced a higher mortality rate than that of GAT or lysozyme. Male mice were more susceptible than female ones. The BSA-induced anaphylactic death could be prevented by pretreating ICR mice with cyproheptadine (histamine and serotonin antagonist) or diphenhydramine (histamine antagonist) and ketanserin (serotonin antagonist). Intravenous injection of saline during anaphylaxis also protected the mice from death. Furthermore, immune serum could transfer the anaphylactic death, and heat (56 degrees C, 4 h) did not destroy its activity. The primary IgG subclass induced by GAT, HoGG or lysozyme was IgG1. There was no qualitative difference in the IgG subclass induced in different strains by different antigens. The IgE class of antibodies was not detectable. These results suggest that there is a non-IgE-mediated anaphylactic death which involves the release of histamine and serotonin that cause the increase of vasopermeability and fatal blood volume loss.
向用牛血清白蛋白(BSA)/完全弗氏佐剂致敏的ICR小鼠静脉注射BSA,可在1小时内特异性诱导过敏性死亡。致敏后直到第8天才会诱导出过敏性死亡,且致敏状态可持续3个月以上。该反应呈剂量依赖性;用剂量高于或等于25微克的BSA攻击的小鼠会发生过敏性死亡。静脉途径比腹腔途径更有效,而皮下注射则无效。完全弗氏佐剂、不完全弗氏佐剂或氢氧化铝中的任何一种抗原都可使小鼠致敏而发生过敏性死亡。抗原与小鼠品系或小鼠性别共同决定了过敏性死亡的易感性。AKR、B10.BR以及ICR品系均易感。猪γ球蛋白(HoGG)抗原诱导的死亡率高于谷氨酸脱羧酶(GAT)或溶菌酶。雄性小鼠比雌性小鼠更易感。用赛庚啶(组胺和5-羟色胺拮抗剂)、苯海拉明(组胺拮抗剂)或酮色林(5-羟色胺拮抗剂)预处理ICR小鼠可预防BSA诱导的过敏性死亡。在过敏反应期间静脉注射生理盐水也可保护小鼠免于死亡。此外,免疫血清可传递过敏性死亡,且加热(56℃,4小时)不会破坏其活性。由GAT、HoGG或溶菌酶诱导产生的主要IgG亚类为IgG1。不同抗原在不同品系中诱导产生的IgG亚类在性质上没有差异。未检测到抗体的IgE类。这些结果表明,存在一种非IgE介导的过敏性死亡,其涉及组胺和5-羟色胺的释放,导致血管通透性增加和致命性血容量丢失。